samedan logo
 
 
 
spacer
home > pmps > summer 2007 > making gas a quality issue
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making Gas a Quality Issue

As the drive for quality continues, regulatory framework surrounding emissions control tightens. Lieve de Paepe at Air Products urges the pharmaceutical industry to foster close partnerships with suppliers to achieve compliance and improve efficiency

Generally used for only the most demanding industrial applications, pharmaceutical manufacturers use speciality gases for a wide range of specialist applications. These applications range from environmental monitoring and control, to using the gas as a key component of the production process itself. For example, many manufacturers use nitrogen as an inerting gas to prevent chemical reactions during production and packaging processes. At other times, pure gases, such as oxygen, are used to create the required reactions or to encourage microbe culture growth. Speciality gases are commonly used in the laboratory and in the area of R&D, and can even be used to carry out specific production processes, such as chemical synthesis. With such critical uses in mind, demand for quality has never been higher, and manufacturers need to be sure that the gas products they are using will deliver the highest standards of accuracy and consistency.

SOURCING HIGH GRADE GASES

When sourcing the highest grade speciality gases, first and foremost manufacturers tend to select those that fulfil the requirements of the monographs of the European, US and Japanese Pharmacopoeias. These standards are widely recognised by manufacturers and gas suppliers alike. In addition, the recent introduction of directives 2004/27/EC and 2004/28/EC (amending directives 2001/83/EC and 2001/82/EC), concerning the use of active pharmaceutical ingredients (API) for human and veterinary use, requires manufacturers to provide an assurance of quality and traceability at every stage of the production process – from R&D, through to production and analysis. As part of this requirement, manufacturers must use high grade speciality gases, which have been produced according to good manufacturing practice (GMP) part II.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
4
     

There are no comments in regards to this article.

spacer
Lieve de Paepe joined Air Products in 1990 after graduating as a Chemical Engineer from the University of Ghent, Belgium. In her current role, Lieve is responsible for supporting the development of speciality gases for a wide range of industrial applications in the pharmaceutical, chemical and environmental management sectors.
spacer
Lieve de Paepe
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Injection vials for vaccines for protection against Covid-19

Düsseldorf, July 02, 2020 The vaccines under development to protect against Covid-19 are, like many other drugs, filled in so-called injection or vials made of type 1 borosilicate glass, also known as vials. The large worldwide demand for vials is met by the Gerresheimer Group's plants in Europe, America and Asia, where they are manufactured to high quality standards for customers in the pharmaceutical industry. The Company has already received initial orders for vials for drugs and vaccines against Covid-19.
More info >>

White Papers

Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs

World Courier

With a fully integrated GxP-compliant transport, storage and distribution system in place and over 140 wholly owned ISO 9001 - certified offices in more than 50 countries, WORLD COURIER, an AmerisourceBergen® company, is the world’s largest and most experienced provider of specialty courier services. It is uniquely positioned to meet the most demanding industry requirements for managing the global distribution of time - and temperaturesensitive pharmaceutical products and IMPs used commercially or in clinical trials.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement